Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Julia A. Balfour"'
Autor:
Julia A. Balfour, Karen L. Goa
Publikováno v:
Drugs. 61:631-638
▴ Bendamustine is a bifunctional alkylating agent with cytotoxic activity against human ovarian and breast cancers in vitro. It shows only partial in vitro cross-resistance with cyclophosphamide, melphalan, carmustine and cisplatin. ▴ Bendamustin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ebea6f2164e1395eb6709fb674194d
https://doi.org/10.2165/00003495-200161050-00009
https://doi.org/10.2165/00003495-200161050-00009
Autor:
Julia A. Balfour, Blair Jarvis
Publikováno v:
CNS Drugs. 14:483-503
Venlafaxine inhibits presynaptic reuptake of both serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine). Dysregulation of one or both of these neurotransmitters has been implicated in anxiety disorders, which often co-exist with de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe0509c1db22e8937754f60b89e37161
https://doi.org/10.2165/00023210-200014060-00006
https://doi.org/10.2165/00023210-200014060-00006
Publikováno v:
Drugs. 59:511-518
▴ Alosetron is a potent and highly selective serotonin 5-HT3 receptor antagonist which has been evaluated for the management of irritable bowel syndrome (IBS). It blocked the fast 5HT3-mediated depolarisation of guinea-pig myenteric and submucosal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec87e6ee089403e62722ac11a06adce1
https://doi.org/10.2165/00003495-200059030-00008
https://doi.org/10.2165/00003495-200059030-00008
Autor:
Julia A. Balfour, Harriet M. Lamb
Publikováno v:
Drugs. 59:115-139
Moxifloxacin is an extended-spectrum fluoroquinolone which has improved coverage against Gram-positive cocci and atypical pathogens compared with older fluoroquinolone agents, while retaining good activity against Gram-negative bacteria. The antibact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79a9977bb48efea6d49decd37c378eb3
https://doi.org/10.2165/00003495-200059010-00010
https://doi.org/10.2165/00003495-200059010-00010
Publikováno v:
Drugs. 58:79-88
▴ Rituximab is a chimaeric monoclonal antibody which specifically binds to the CD20 antigen on normal and malignant B lymphocytes. It produces antibody-dependent cell- and complement-mediated cytotoxicity in these cells. ▴ Rituximab reduced perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5730d15135e381157f48ffa09ac28fea
https://doi.org/10.2165/00003495-199958010-00009
https://doi.org/10.2165/00003495-199958010-00009
Autor:
Julia A. Balfour, Harriet M. Lamb
Publikováno v:
Disease Management and Health Outcomes. 6:225-239
Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality and is associated with the consumption of considerable health resources worldwide. Initial treatment of patients with CAP is often empirical. Growing concern about the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8cda7d1da059cab9e6428b03ac62d88
https://doi.org/10.2165/00115677-199906040-00005
https://doi.org/10.2165/00115677-199906040-00005
Autor:
Stuart Noble, Julia A. Balfour
Publikováno v:
BioDrugs. 11:359-364
Becaplermin is a recombinant human platelet-derived growth factor B-chain homodimer (rh-PDGF-BB) for topical treatment of full-thickness diabetic neuropathic ulcers and pressure ulcers. rh-PDGF-BB promotes wound healing, probably by increasing granul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd14a689435d451150e679a190c0b10
https://doi.org/10.2165/00063030-199911050-00007
https://doi.org/10.2165/00063030-199911050-00007
Autor:
Nishan S. Gunasekara, Julia A. Balfour
Publikováno v:
Disease Management and Health Outcomes. 5:41-54
Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality and is associated with the consumption of considerable health resources worldwide. Initial treatment of patients with CAP is often empirical. Growing concern about the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d01650c0b3ac7a2ff4680d6f26e62b8
https://doi.org/10.2165/00115677-199905010-00004
https://doi.org/10.2165/00115677-199905010-00004
Autor:
Heather D. Langtry, Julia A. Balfour
Publikováno v:
Drugs. 56:273-297
Azithromycin in an azalide antimicrobial agent active in vitro against major pathogens responsible for infections of the respiratory tract, skin and soft tissues in children. Pathogens that are generally susceptible to azithromycin include Haemophilu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1fe769c9f4221b62bab66e58a21124f
https://doi.org/10.2165/00003495-199856020-00014
https://doi.org/10.2165/00003495-199856020-00014
Autor:
Caroline M. Perry, Julia A. Balfour
Publikováno v:
Disease Management and Health Outcomes. 4:277-293
HIV disease is a serious global health problem and a major cause of morbidity and mortality worldwide. It has recently been estimated that more than 30 million adults and 1.1 million children are infected with HIV; it is expected that 40 million peop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeba1639c531ba0b8cc37efc8f0cb122
https://doi.org/10.2165/00115677-199804050-00004
https://doi.org/10.2165/00115677-199804050-00004